AZIYO BIOLOGICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operation and Financial Condition.

On January 9, 2023, Aziyo Biologics, Inc. (the "Company") issued a press release announcing its preliminary net sales results for the fourth quarter and full year ended December 31, 2022. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



Exhibit No.   Description
  99.1          Press Release of Aziyo Biologics, Inc., dated January 9, 2023

104           Cover Page Interactive Data File (formatted as Inline XBRL document)

© Edgar Online, source Glimpses